Name
Omacetaxine
Alternate Names
Homoharringtonine
Omacetaxine mepesuccinate
Omapro
Synribo
Abbreviations
INN
Category
Chemotherapy
Subcategory
Alkaloid
Protein inhibitor
NSC Number
102816
Primary Site
Myelodysplastic syndrome (MDS)
Histology
None
Remarks
Approved under the FDA's accelerated approval program October 26, 2012 to treat CML.
Coding
This drug should be coded